-3 -Among polypeptide neurotrophic factors that participate to neuronal differentiation during CNS development, insulin-like growth factor-1 (IGF-1) is of particular interest. IGF-1 is the growth factor that initiates axon specification and, thus, plays an essential role in the establishment of neuronal polarity (Sosa, 2006) . IGF-1 is also highly expressed in the mature nervous system and has been shown to exert neuroprotective effects upon numerous neuronal populations (D'Mello et al., 1993; Galli et al., 1995; Kaspar et al., 2003; Leinninger et al., 2004; Vincent et al., 2004) . IGF-1 is a potent agent for rescuing neurons from apoptosis and the ability of IGF-1 to promote neuronal survival is associated with its ability to prevent apoptosis. In the same manner, pituitary adenylyl cyclase activating polypeptide (PACAP) is a unique polypeptide neurotransmitter capable of providing neuroprotective or neurotrophic action upon various neuronal populations throughout the CNS (Arimura et al., 1994; Morio et al., 1996; Takei et al., 1998; Takei et al., 2000; Villalba et al., 1997) . PACAP also exerts chemotropic effects on developing growth cones (Guirland, 2003) and plays a crucial role in the control of cerebral cortical progenitor division (Carey et al., 2002; Suh et al., 2001 ).
Neurotrophic activities of both IGF-1 and PACAP are initiated by specific kinase-dependent signalling cascades. IGF-1 triggers autophosphorylation of its cognate tyrosine kinase receptor on multiple tyrosines. These phosphotyrosine residues serve as platforms for the binding and subsequent phosphorylation of various signalling molecules, thus initiating multiple signalling cascades. For instance, the phosphatidyl inositol 3-kinase (PI3-K)/Cdc42 pathway is essential for the determination of neuronal polarity (Sosa et al., 2006) while the PI3-K/Akt pathway mediates the IGF-1 anti-apoptotic activity . On the other hand, PACAP has been shown to protect neurons against apoptosis via a signalling pathway involving Gs-protein coupled PAC1 receptor, protein kinase A (PKA) and mitogen-activated protein kinase (Erk1,2) (Vaudry et al., 1999; Villalba et al., 1997) . Similarly, the chemotropic effects of PACAP on developing growth cones are mediated by the cAMP/PKA signalling pathway (Guirland et al., 2003) . In contrast, the nature of downstream effector proteins that are phosphorylated upon activation of each of these signalling cascades remains largely unexplored.
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Results and Discussion

Efficient enrichment of phosphoproteins from IGF-1-or PACAP-treated cortical neurons afforded by metal-affinity chromatography
To get an unbiased overview of the IGF-1 and PACAP receptor-associated phosphoproteomes in cortical neurons, we used a phosphoproteomic approach that we adapted for the first time to neuronal cultures containing only 10 millions neurons. This approach was based on phosphoprotein enrichment by metal affinity chromatography (PMAC), followed by the separation of affinity-purified proteins onto 2-D gels and their identification by MALDI-TOF mass spectrometry (MS). Phosphopeptides resulting from trypsin digestion of phosphoproteins were also purified on TiO 2 microcolumns to identify phosphorylated residues by MS/MS ( Figure 1A ) (Collins et al., 2005; Larsen et al., 2005) . We first evaluated the efficiency of the PMAC procedure for enrichment of phosphorylated proteins by immunoblotting using various phosphoprotein-specific antibodies. As illustrated in Figure 1B , treating cortical neurons for 10 min with PACAP (1 nM) resulted in the phosphorylation of PKA substrates. The majority of phosphorylated PKA substrates were retained on the PMAC column. Similarly, the majority of proteins phosphorylated on tyrosine residues upon IGF-1 treatment (10 min, 2.5 ng/ml) bound to PMAC beads ( Figure 1C ). Finally, analysis of specific signalling proteins such as Erk1,2 and Akt revealed that IGF-1-( Figure 1C ) or PACAP-(not shown) generated phospho-Erk1,2 and phospho-Akt were entirely retained on the PMAC column. These experiments also indicated that a minor fraction of total Erk1,2 and Akt was retained on PMAC beads (and then eluted with phosphate buffer), underpinning the low phosphorylation stoichiometry of several molecules involved in signalling cascades initiated by these neurotrophic factors in neurons.
Phosphorylation of a common set of proteins in IGF-1-or PACAP-treated neurons
2-D gel analysis of PMAC-purified proteins from neurons challenged with either IGF-1 or PACAP revealed that both treatments induced a large increase in the amount of proteins retained by PMAC beads (Figure 2A , upper gels). To assess possible binding of nonphosphorylated proteins on PMAC beads together with the phosphorylated ones, we HAL author manuscript inserm-00151734, version 1
-5 -performed metabolic labelling of neurons with 32 P orthophosphate prior to the PMAC procedure and separated radioactively labelled proteins onto 2-D gels. These experiments confirmed that IGF-1 and PACAP induced a large increase in the phosphorylation state of a set of neuronal proteins ( Figure 2A , lower gels). Further supporting efficient binding of phosphoproteins to the PMAC beads, we only detected traces of radioactive proteins in the PMAC flow-through fraction ( Figure S1 ). However, comparing silver-stained and 32 P-labelled 2-D protein patterns in the PMAC-purified fraction revealed some differences. Indeed, a number of proteins retained on PMAC beads were not labelled with 32 P (Figure 2A ).
Therefore, only 32 P-labelled proteins that were retained on PMAC beads were further analyzed. Seventy spots (or trains of spots) fulfilling this criterion were identified by MALDI-TOF MS-based peptide mass fingerprinting. These spots corresponded to 51 different proteins, which were assigned to eight major protein categories with regard to their biological function ( Figure 2B ). These include nuclear proteins, signalling or adhesion molecules, cytoskeleton proteins, chaperone proteins, translation factors or proteins controlling translation, metabolic enzymes, proteasome subunits and proteins involved in the regulation of axonal growth ( Figure 2B , see also Table S1) .
Surprisingly, more than 80% of the identified phosphoproteins were phosphorylated following exposure of neurons to both IGF-1 and PACAP ( Figure 2C ), which, however, are known to initiate distinct signalling cascades. We thus sought to identify phosphorylated residues in a subset of proteins phosphorylated in response to both IGF-1 and PACAP treatments, using a procedure based on the enrichment of phosphopeptides resulting from trypsin digestion of these phosphoproteins on titanium dioxide (TiO 2 ) microcolumns. We first validated the selectivity for phosphopeptides of the TiO 2 beads on tryptic peptides originating from collapsin response mediator protein-4 (CRMP-4, spot 15, Table S1 and Figure 2A ), a protein known to be phosphorylated on several serine and threonine residues. Comparing MALDI-TOF MS spectra of the tryptic digest of CRMP-4 without TiO 2 enrichment and after TiO 2 chromatography indicated that only a few peptides were eluted off the TiO 2 column, compared with the unpurified peptide mixture ( Figure 1D ). (Table S2 ).
Altogether, these findings indicate that IGF-1 and PACAP induce similar phosphorylation profiles in cortical neurons, even though they are known to activate distinct signalling cascades. In contrast, selective activation of group I metabotropic glutamate receptor by (S)-3,5-dihydroxyphenylglycine (DHPG), which like IGF-1 and PACAP is known to prevent neuronal apoptosis (Copani et al., 1998) , induced the phosphorylation of a distinct protein pattern in neurons ( Figure S2 ). Overall, DHPG was less potent than IGF-1 or PACAP to induce phosphorylation of neuronal proteins. Only 18 out of the 51 proteins phosphorylated upon PACAP or IGF-1 treatments were phosphorylated in neurons following a DHPG exposure, which induced the phosphorylation of three additional proteins that were not identified in the PACAP-or IGF-1-associated phosphoproteomes. This indicates that various treatments supporting neuronal survival do not trigger phosphorylation of a unique set of neuronal proteins.
Transactivation of EGF receptor in neurons exposed to IGF-1 or PACAP
We hypothesized that the common phosphorylation pattern detected in neurons exposed to PACAP or IGF-1 could result from the transactivation of a tyrosine kinase receptor following PACAP exposure. Indeed, PACAP was previously found to increase TrkA tyrosine kinase activity in PC12 cells and to activate TrkB in hippocampal neurons (Lee et al., 2002; Rajagopal et al., 2004) . However, these transactivation processes required a longer PACAP exposure (3 h), compared with those performed in our study (10 min). Alternatively, ligands -7 -of Gs-coupled receptors can induce a rapid transactivation of the epidermal growth factor receptor (EGFR) through a signalling cascade involving cAMP and PKA (Bertelsen et al., 2004) . Consistently, we showed that PACAP, like IGF-1, stimulated the phosphorylation of the EGFR on Tyr 845 and on Tyr 1068 ( Figure S3A ). Tyrosine phosphorylation of the EGFR induced by PACAP was strongly decreased by Rp-cAMPS (10 μM), an inhibitor of PKA, but was unchanged in the presence of U73122, a phospholipase Cβ inhibitor, indicating that transactivation of EGFR in neurons exposed to PACAP was dependent on PKA activation ( Figure S3A ). Since autophosphorylation of the EGFR on Tyr 1068 is known to be involved in the activation of the mitogen-activated protein kinase Erk1,2 pathway, we examined whether EGFR transactivation was involved in the increase in Erk1,2 phosphorylation measured in neurons exposed to PACAP. As shown in Figure S3B , AG1478 (250 nM), a specific inhibitor of EGFR kinase activity, strongly decreased the phosphorylation of Erk1,2 induced by PACAP. Rp-cAMPS also strongly attenuated the phosphorylation of Erk1,2 induced by PACAP, consistent with the role of PKA in EGFR transactivation. We next examined whether EGFR transactivation contributed to the common phosphorylation events detected in neurons challenged with IGF-1 or PACAP. Blocking EGFR activity with AG1478 only suppressed the phosphorylation of three out of forty-eight proteins that were phosphorylated upon PACAP treatment and purified on PMAC beads ( Figure S3C ). Moreover, AG1478 treatment did not alter protein phosphorylation in neurons exposed to IGF-1 (not shown).
Taken together, these results indicate that EGFR transactivation only plays a minor role in generating the common IGF-1 and PACAP-associated phosphoproteomes in cortical neurons.
Transactivation of PAC1 receptor in neurons exposed to IGF-1
We next examined the possibility that IGF-1R was transactivated upon PACAP treatment. As illustrated in Figure 3A , IGF-1, but not PACAP, increased the phosphorylation of the IGF-1R
on Tyr 1135/1136 , two residues that are known to be involved in the activation of the IGF-1R. -9 -3D). These include proteins involved in neuronal growth and migration such as drebrin (Hayashi and Shirao, 1999) , doublecortin (Bai et al., 2003; Tanaka et al., 2004) or GAP-43 (Aigner et al., 1995) and proteins potentially involved in the control of apoptosis, such as translation Elongation Factor-2 (Marin et al., 1997) , the heterogeneous ribonucleo-protein hnRNP-D0 (Lapucci et al., 2002) , the phosphatase inhibitor SET (Fan et al., 2003 ) and 14-3-3
proteins (Datta et al., 2000) . Consistent with a critical role of PAC1R transactivation in IGF-1R-associated phosphoproteome, the IGF-1-evoked increase in the phosphorylation of Akt at Ser 473 (a process involved in Akt activation by the PI3-K pathway) was markedly reduced in PAC1 -/-neurons, compared with that measured in WT neurons ( Figure 3E ). This result demonstrates a role of PAC1R transactivation in the initial steps of the signalling cascade initiated by IGF-1R activation. (VSV-PAC1R) using an anti-VSV antibody revealed that PAC1Rs constitutively associated with IGF-1Rs ( Figure 4A ). We next examined the possibility that PAC1R transactivation occurred via stimulation of a kinase that regulates PAC1 receptor activity, using inhibitors of kinases known to be activated upon IGF-1R stimulation. Treating neurons with the Src family kinase inhibitor PP2, but not with its inactive analogue PP3 (10 μM each), entirely suppressed the induction of cAMP production by IGF-1 ( Figure 4C ). The IGF-1-mediated cAMP production was similarly inhibited by SU6656 (1 μM), a more selective inhibitor of this tyrosine kinase subfamily (Blake et al., 2000) . Further supporting a role of Src family kinases in PAC1R transactivation, IGF-1 did increase Src activity (assessed by phosphorylation of Tyr 416 in the activation loop of the kinase domain, Figure 4B ) and induced PAC1R phosphorylation on tyrosine residues in cortical neurons, an effect that was prevented by SU6656 ( Figure 4A ). In contrast, the increase in cAMP production in IGF-1-treated neurons HAL author manuscript inserm-00151734, version 1
Role of Src family kinases in IGF-
-10 -was neither prevented by wortmannin (100 nM), a PI3K inhibitor, nor by PD98056 (10 μM), an inhibitor of the Erk1,2 signalling pathway, nor by the PKC inhibitor GF109203X (10 μM, Figure 4B ). Together, these findings suggest that PAC1R transactivation in IGF-1-treated neurons may result from PAC1R phosphorylation by a Src family kinase within a protein complex formed by PAC1 and IGF-1 receptors.
Role of PAC1 receptor transactivation in IGF-1 anti-apoptotic activity
The ability of IGF-1 to promote neuronal survival has been attributed in part to the PI3-K/Akt pathway . As we showed that PAC1R transactivation was involved in the phosphorylation and activation of Akt upon IGF-1 treatment, we addressed the possibility that -11 -increased the phosphorylation of Akt at Ser 473 during the time frame of apoptosis induction (8 h, Figure 5D ). As described above in cortical neurons, IGF-1-mediated Akt phosphorylation was strongly reduced in CGNs from PAC1 -/-mice, further supporting the involvement of PAC1R transactivation in the recruitment by IGF-1 of the anti-apoptotic PI3-K/Akt signalling pathway in CGNs.
In conclusion, our results demonstrate that a procedure based on the enrichment of phosphoproteins by metal affinity chromatography followed by the purification of Genetic inactivation of the genes encoding PACAP or PAC1R in mice generates complex CNS phenotypic changes including psychomotor abnormalities, altered synaptic plasticity and memory performance and dysfunctions of circadian rhythms (Hashimoto et al., 2006) . These phenotypes may result from both developmental defects and alteration of PAC1R-mediated signalling. Whether the loss of IGF-1-mediated PAC1R transactivation contributes to these behavioural abnormalities requires further investigation. In any case, the complex signalling network associated to IGF-1Rs described herein may account for the unique properties of this growth factor to promote neuronal polarity (Sosa et al., 2006) and the survival of numerous neuronal populations (Russo et al., 2005) , compared with other neurotrophins.
Materials and methods
Animals, plasmids and reagents
C57BL/6J mice were obtained from Charles Rivers. The PAC1R-deficient mice were previously described (Jamen et al., 2000) .
Using PCR, the mouse PAC1R (IMAGE 6852762) was N-terminally tagged with the sequence encoding an eleven amino acid epitope (YTDIEMNRLGK) of the VSV glycoprotein. The amplified DNA was directly subcloned into the NheI and EcoRI restriction sites of pCI vector, yielding the pCI/VSV-mPAC1 construct. cartridge (4.0-mm inner diameter, catalogue number 5020-08520-5u-TiO 2 ), purchased from GL Sciences Inc. 32 P-orthophosphoric acid (5 mCi/mmol) was obtained from GE Healthcare.
Primary neuronal cultures and transfection
Primary cultures of cortical neurons were prepared using the method of El Etr et al. (el-Etr et al., 1989) . Briefly, cortices were removed from 17-day-old wild-type or PAC1 -/-mouse embryos and mechanically dissociated in PBS containing 33 mM glucose. Cells were seeded on either 100-mm culture dishes (12 x 10 6 cells/dish), 6-well plates (2 x 10 6 cells/well) or 24-well plates (5 x 10 5 cells/well), and maintained for 7 days at 37°C in a humidified atmosphere containing 95% CO 2 in a serum-free culture medium including a 1:1 mixture of Dulbecco's modified Eagle's medium and F12 nutrient supplemented with D-glucose (33 mM), L-HAL author manuscript inserm-00151734, version 1 glutamine (2 mM), NaHCO 3 (13 mM), HEPES buffer (5 mM, pH 7.4), penicillinstreptomycin (100 IU/ml-100 μg/ml, respectively) and a mixture of salt and hormones containing insulin (25 μg/ml), transferrin (100 μg/ml), progesterone (20 nM), putrescine (60 mM) and Na 2 SeO 3 (30 nM). Under these conditions, cultures were shown to be highly enriched in neurons by immunocytochemistry using a mouse anti-MAP2 antibody (clone AP20, Sigma) and devoid of glial cells, as assessed by the absence of immunolabelling using a rabbit antibody against glial fibrillary acid protein (Dako, not shown).
Primary cultures of CGNs were prepared from 7-day-old WT or PAC1 -/-mice as previously described (Van Vliet et al., 1989) . Freshly dissected cerebella were incubated with 0.25 mg/ml trypsin for 10 min at 37°C. Trypsin inhibitor (0.5 mg/ml) and DNAase 1 (0.08 mg/ml)
were added and cerebella were mechanically dissociated. Cells were seeded on 15-mm glass coverslips (3 x 10 5 cells/coverslip) and grown for 7 days in culture medium composed of basal Eagle's medium, supplemented with KCl (30 mM final), glutamine (2 mM), HEPES buffer (5 mM, pH 7.4), penicillin-streptomycin (100 IU/ml-100 μg/ml, respectively) and 10% fetal calf serum. Cytosine arabinoside (30 μM) was added 24 h after plating to prevent proliferation of non-neuronal cells.
Cultures were transfected 6 days after seeding with the pCI/VSV-PAC1 plasmid (1 μg DNA/10 6 cells) by using Lipofectamine 2000, according to the manufacturer's instructions.
Experiments were carried out 24 h after transfection.
Phosphoprotein enrichment
Neuronal protein extracts were enriched in phosphoproteins using the PMAC kit. Neurons, grown in 100-mm culture dishes for 7 days (~10 7 cells per dish) were incubated for 3 h in HEPES saline buffer containing (in mM) HEPES, 20, pH 7.4; NaCl, 150; KCl, 4.2; CaCl 2 , 0.9; MgCl 2 0.5 and glucose, 10) and then exposed to indicated treatments for 10 min in HEPES saline buffer. Cells were scraped off, spun at 1,000 x g, washed three times in PBS containing 33 mM glucose and frozen at -80°C. The cells were lysed and cell lysates (4 mg protein) were loaded onto PMAC columns according to the manufacturer's instructions.
Proteins retained by the column were eluted with 3 ml of phosphate buffer (NaCl, 0.5 M; Na-HAL author manuscript inserm-00151734, version 1 -14 -phosphate, 20 mM, pH 7.2). Eluted proteins were precipitated with 10% trichloroacetic acid for 2 h at 4°C. Samples were centrifuged at 10,000 x g for 30 min and pellets were washed three times with diethyl ether.
Two-dimensional gel electrophoresis
Protein pellets were resuspended in 350 μl of isoelectrofocusing medium containing urea (7 M), thiourea (2 M), CHAPS (4%), ampholines (preblended, pI 3.5-9.5, 8 mg/ml, GE Healthcare), dithiothreitol (DTT, 100 mM), tergitol NP7 (0.2%, Sigma) and traces of bromophenol blue. Proteins were then resolved onto 2-D gels and stained with silver, as previously described (Delcourt et al., 2005) . Gels to be compared were always processed and stained in parallel. Gels were scanned using a computer-assisted densitometer. 32 P labelled proteins were detected by autoradiography (3 day exposure).
MALDI-TOF mass spectrometry and protein identification
Protein spots were excised and digested in-gel using trypsin (Gold, Promega), as previously described (Delcourt et al., 2005) . Digested samples were dehydrated in a vacuum centrifuge, solubilized in 10 μl of formic acid (2%), desalted using C18 ZipTips (Millipore, elution with 10 μl of 0.1% TFA -50% acetonitrile) and concentrated to a 1-μl volume. 0.3 μl, mixed with the same volume of α-cyano-4-hydroxy-trans-cinnamic acid (10 mg/ml in 0.1% TFA in 50% acetonitrile), were deposited on a 384-well MALDI target using the dry droplet procedure and air-dried at room temperature. Analyses were performed using an UltraFlex MALDI-TOF/TOF mass spectrometer (Bruker-Franzen Analytik) operating in the reflectron mode with a 20-kV accelerating voltage and a 70-ns delayed extraction. Mass spectra were acquired in the automatic mode using the AutoXecute™ module of Flexcontrol™ (laser power ranged from 30 to 70%, 500 shots). Spectra were analyzed using FlexAnalysis™ software (BrukerFranzen Analytik) and autoproteolysis peptides of trypsin (m/z 842.51, 1045.56, and 2211.10)
were used as internal calibrates. Peptides were selected in the mass range of 900-4,000 Da.
Identification of proteins was performed using the Mascot software package (version 2.1, Matrixscience) against the Swiss-Prot database. The following parameters were used for database interrogation: mass tolerance of 50 ppm (even if the mass accuracy of our analyses HAL author manuscript inserm-00151734, version 1
-15 -was usually better than 20 ppm); fixed chemical modification: carbamidomethylation of cysteins; variable chemical modification, oxidation of methionines; matching peptides with one missed cleavage accepted only when they included two consecutive basic residues or when arginine or lysine residues were followed by one or several acidic residues inside the peptide amino acid sequence. Mascot scores greater than 53 were considered as significant (p<0.05) for Swiss-Prot database interrogation.
MS/MS spectra were acquired on the UltraFlex MALDI-TOF/TOF mass spectrometer employing the LIFT TM technology. This mode enables the production of ions from laserinduced metastable decay. A relatively low voltage of 8 kV was initially applied for ion acceleration. The parent ion mass selector window was from 0.5 to 1% range. Fragments generated from laser-induced dissociation were subsequently raised to a higher potential (19 kV) in the LIFT cell. Automatic calibration was performed using the Flexcontrol TM software for the parent ion and the FlexAnalysis TM software for the entire spectrum. A mass deviation of 0.5 Da was allowed for database interrogation for fragment ions. Database interrogation was performed using the Mascot software against the Swiss-Prot database, with phosphoSer/Thr/Tyr as variable modification. Mascot scores greater than 25 were considered as significant (p<0.05) for Swiss-Prot database interrogation.
Purification of phosphorylated peptides on TiO 2 microcolumns
TiO 2 microcolumns (3-mm length) were packed in GELoader tips as described by Larsen et al. (Larsen et al., 2005) . Lyophilized samples digested with trypsin were solubilized in 10 μl of acetonitrile 80%, TFA 0.1%, dihydroxybutyric acid (DHB) 200 mg/ml and loaded onto the microcolumns. The columns were washed with 10 μl of the DHB solution and 10 μl of 80% acetonitrile, 0.1% TFA. Peptides retained by the column were eluted with 5 μl NH 4 OH (pH 10.5). 
Co-immunoprecipitation
Cortical neurons transfected with the pCI/VSV-PAC1R construct (2 x 10 7 neurons per assay),
were lysed in solubilization buffer containing HEPES, 50 mM pH 7.5; EDTA, 1 mM; Triton X-100, 1%; SDS, 0,1%; Na 3 VO 4 , 1 mM; Na-pyrophosphate, 30 mM; NaF, 10 mM and a protease inhibitor cocktail. Solubilized proteins were incubated overnight at 4°C with 5 μl of rabbit non-immune serum or the polyclonal anti-VSV antibody. Samples were then incubated for 1 h with 50 μl protein of protein A Sepharose beads. After five washes in PBS, immunoprecipitated proteins were eluted in SDS sample buffer.
Immunoblotting
Proteins were resolved on 12.5% gels and transferred electrophoretically onto nitrocellulose membranes (Hybond-C, GE Healthcare). Membranes were incubated in blocking buffer (TrisHCl, 50 mM, pH 7.5; NaCl, 200 mM; Tween 20, 0.1 % and skimmed dry milk, 5%) for 1 h at room temperature and incubated overnight with primary antibodies, all at 1:1,000 dilution, in blocking buffer. Blots were washed three times with blocking buffer and incubated with either horseradish peroxidase-conjugated anti-rabbit or anti-mouse antibodies (GE Healthcare, 1:3,000 in blocking buffer) for 1 h at room temperature. Immunoreactivity was detected with an enhanced chemiluminescence method (Renaissance Plus, Perkin Elmer).
Measurement of cAMP production
Neurons grown in 24-well culture dishes were preincubated with HEPES saline buffer for 3 h and then exposed for 5 or 10 min to the indicated treatments in 0.25 ml HEPES saline buffer supplemented with 0.1% BSA and 3-isobutyl-1-methyl xanthine (IBMX, 1 mM), a nonspecific phoshodiesterase inhibitor. Cells were then lysed by adding 0.25 ml Triton X-100 (0.1%). Intracellular cAMP levels were measured using a homogenous time-resolved fluorescence-based cAMP dynamic kit (CisBio International) according to the manufacturer's instructions.
Induction of apoptosis, immunocytochemistry and measurement of apoptotic nuclei
CGNs grown for 7 days on glass coverslips were washed three times with a serum-free medium composed of basal Eagle's medium supplemented with glucose (30 mM), glutamine (2 mM), HEPES buffer (5 mM, pH 7.4) and penicillin-streptomycin (100 IU/ml-100 μg/ml, respectively), and incubated for 8 h in this medium in the presence of the indicated treatments.
Cells were then exposed to propidium iodide (3 μg/ml) for 10 min, to assess possible lack of membrane integrity associated to cell necrosis. CGNs were then washed twice with PBS containing 33 mM glucose, fixed with 4% paraformaldehyde in PBS (30 min at 4°C) and incubated with Hoechst 33258 (1 μg/ml for 10 min at room temperature). VSV-PAC1-transfected CGNs were detected by immunolabelling with a monoclonal anti-VSV antibody
(1:1,000 dilution) and an alexa green-labelled anti-mouse antibody (1:2,000 dilution). Nuclear (A) Cortical neurons grown for 7 days in 100-mm culture dishes (~ 10 7 neurons) were incubated for 3 h in phosphate-free HEPES buffer in the absence (top gels) or presence of 32 Porthophosphoric acid (bottom gels, 5 mCi/dish) before they were exposed or not to either IGF-1 (2.5 ng/ml) or PACAP (1 nM) for 10 min. PMAC phosphoprotein-enriched fractions were separated onto 2-D gels and proteins were revealed either by silver staining or autoradiography. Matching between silver-stained and 32 P labelled spots was performed using
